Australian Competition and Consumer Commission v Willesee Healthcare Pty Ltd [2011] FCA 301

Australian Competition and Consumer Commission v Willesee Healthcare Pty Ltd [2011] FCA 301

The first to fifth respondents engaged in misleading and deceptive conduct, and made false representations regarding the quality, performance, and risk-reduction of allergy diagnosis and treatment via NAET, which lacked scientific validity. Declarations, compliance training, corrective advertising, and cost orders were appropriate due to the risk of harm to consumers and the public interest in accurate representation.

Jurisdiction
Australia
Judgment Date
31 March 2011
Procedural Posture
Civil / Final Orders and Declarations by Consent
Outcome
Declarations and orders made by consent; undertakings accepted; injunction granted against Theoliza Pty Ltd; costs awarded.
Legal Topics
['misleading and Deceptive Conduct' 'false Representations' 'diagnosis and Treatment of Allergies' 'nambudripad Allergy Elimination Technique' 'consent Orders' 'compliance Training' 'corrective Advertising']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Civil / Final Orders and Declarations by Consent

  1. 1 ["Whether respondents' representations in relation to NAET constitute misleading and deceptive conduct under the Trade Practices Act 1974 (Cth)" 'Whether respondents falsely represented quality and performance characteristics of their services' "Whether respondents' treatments create risk for clients by promoting ineffective allergy diagnosis and treatment" 'Appropriateness and sufficiency of declaratory and injunctive relief and corrective advertising']

Ratio Decidendi

The first to fifth respondents engaged in misleading and deceptive conduct, and made false representations regarding the quality, performance, and risk-reduction of allergy diagnosis and treatment via NAET, which lacked scientific validity. Declarations, compliance training, corrective advertising, and cost orders were appropriate due to the risk of harm to consumers and the public interest in accurate representation.

Court Disposition

Declarations and orders made by consent; undertakings accepted; injunction granted against Theoliza Pty Ltd; costs awarded.

Orders

  • ['Declarations that respondents contravened ss 52, 53(aa), 53(c), 55A Trade Practices Act 1975 (Cth)' 'Undertakings for 3 years not to make similar representations' 'Injunction against Theoliza Pty Ltd for 3 years against misleading allergy representations' 'Compliance training regarding Competition and Consumer...